Agenus (AGEN) Change in Receivables (2010 - 2026)
Agenus' (AGEN) quarterly Change in Receivables came in at $4.7 million in Q1 2026, up 4480.56% year-on-year from $103284.4 in Q1 2025, and up 181.77% quarter-over-quarter from $1.7 million in Q4 2025.
Agenus (AGEN) Change in Receivables (2010 - 2026) Analysis & Trends
Agenus' Change in Receivables history runs 17 years deep, the most recent figure standing at $4.7 million for Q1 2026.
- On a quarterly basis, Change in Receivables rose 4480.56% year-over-year to $4.7 million in Q1 2026; TTM through Mar 2026 was $6.6 million, a 6016.22% increase from a year earlier, with the FY2025 full-year figure at $1.7 million, up 106.82% from the prior year.
- Change in Receivables climbed to $4.7 million in Q1 2026 per AGEN's latest filing, from $1.7 million in the prior quarter.
- Across five years, Change in Receivables topped out at $24.8 million in Q4 2023 and bottomed at -$25.3 million in Q1 2024.
- The 5-year median for Change in Receivables is -$108000.0 (2025), against an average of $262000.0.
- Across the five-year window, Change in Receivables plunged 1862.9% in 2024 and jumped 4480.56% in 2026, its largest moves.
- Year by year, Change in Receivables stood at -$7.2 million in 2022, then jumped by 443.97% to $24.8 million in 2023, then tumbled by 98.91% to $269000.0 in 2024, then soared by 524.16% to $1.7 million in 2025, then soared by 181.77% to $4.7 million in 2026.
- Per Business Quant, the three latest AGEN Change in Receivables figures stand at $4.7 million (Q1 2026), $1.7 million (Q4 2025), and -$183000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Agenus | 184.05 Mn | 177.29 Mn | 33.74 Mn | 4.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.73 Mn |
| Mar 31, 2026 | 4.73 Mn |
| Dec 31, 2025 | 1.68 Mn |
| Dec 31, 2025 | 1.68 Mn |
| Sep 30, 2025 | -183,000.00 |
| Sep 30, 2025 | -183,000.00 |
| Jun 30, 2025 | 340,000.00 |
| Jun 30, 2025 | 340,000.00 |
| Mar 31, 2025 | -108,000.00 |
| Mar 31, 2025 | -108,000.00 |
| Dec 31, 2024 | 269,000.00 |
| Dec 31, 2024 | 269,000.00 |
| Sep 30, 2024 | -492,000.00 |
| Sep 30, 2024 | -492,000.00 |
| Jun 30, 2024 | 220,000.00 |
| Jun 30, 2024 | 220,000.00 |
| Mar 31, 2024 | -25.34 Mn |
| Mar 31, 2024 | -25.34 Mn |
| Dec 31, 2023 | 24.77 Mn |
| Dec 31, 2023 | 24.77 Mn |